A prostaglandin analogue (ONO-802) in treatment of missed abortion, intrauterine fetal death and hydatiform mole: a dose-finding trial

N Garcea, Ruggero Dargenio, V. Panetta, E Moneta, Giulietta Tancredi, Aldo Giannitelli
In: European Journal of Obstetrics & Gynecology and Reproductive Biology · 1987 · vol. 25(1) , pp. 15–22 · doi:10.1016/0028-2243(87)90087-6 · PMID:3595971 · W2098534115
article OA: bronze CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

Abstract

Forty-eight patients affected with missed abortion, intrauterine fetal death and hydatiform mole were treated with vaginal suppositories containing 1 mg of 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (ONO-802). The patients were divided into two treatment groups. The first, Group A, was given one vaginal suppository every 3 h to a maximum of five suppositories. The product of conception was expelled in 95.8% of patients. In Group B the maximum number of suppositories was reduced to three. The product of conception was expelled in 100% of cases and the average duration of treatment was similar to that for the first group. Although side-effects were mild in both groups, they were reduced in the patients of Group B.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (21)

SciLite annotations

chemicals 3
prostaglandin dimethyl ethynylboronate methyl ester

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK